Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Pharmacovigilance Software Market to Surpass USD 530 Million by 2032 Amid Rising Compliance Needs

globenewswire.com
ACN Accenture PLC is mentioned as a company in the pharmacovigilance software market, indicating its involvement in providing solutions within this sector. The article does not provide specific sentiment towards Accenture but lists it among industry players. CTAS Clarivate is listed as a company involved in the pharmacovigilance software market. The article does not offer specific sentiment but includes it in a list of industry participants. INFY Infosys Limited is listed as a company operating within the pharmacovigilance software market. The article includes it among industry players without specific positive or negative commentary. IQV IQVIA Inc. is mentioned as a company in the pharmacovigilance software market. The article lists it among industry participants without providing specific sentiment. ORCL Oracle Corporation is listed as a company involved in the pharmacovigilance software market. The article includes it in a list of industry players without specific sentiment. WIT Wipro Limited is mentioned as a company in the pharmacovigilance software market. The article lists it among industry participants without providing specific sentiment or performance details.

Pharmacovigilance Software Market to Surpass USD 530 Million by 2032 Amid Rising Compliance Needs Dublin, July 06, 2026 (GLOBE NEWSWIRE) -- The "Pharmacovigilance & Drug Safety Software Market by Software Type, Organization Size, Pharmacovigilance Type, Deployment Mode, Clinical Trial Phase, End User, Application - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The Pharmacovigilance & Drug Safety Software Market is set for significant growth, projected to reach USD 531.33 Million by 2032, fueled by a CAGR of 6.28%. Central to pharmaceutical, biotechnology, and medical device organizations, this software serves as a crucial compliance framework. The market is driven by increased adverse event reporting, stringent post-marketing surveillance, and the necessity to manage safety data across global regulatory systems like FDA FAERS, EMA EudraVigilance, and WHO VigiBase. These tools are enhancing strategic planning, risk mitigation, and market entry strategies.

Advancements in Pharmacovigilance Software

Shifts in the landscape show a transition from document-centric to data-centric software ecosystems. The emphasis on interoperability and automation reflects regulators' preferences for structured submissions and proactive risk management. This shift encourages replacing fragmented legacy systems with comprehensive cloud-based platforms, aiding competitively aligned decision-making.

Integration and Transformation in Safety Models

Converging safety functions and integrating electronic health records, patient support systems, and regulatory intelligence are redefining pharmacovigilance tools. Enhanced demand for cybersecurity, multilingual operations, and standardized exchanges underscore the need for a unified safety model. Such integration offers competitive advantages through improved efficiency and regulatory alignment.

The Role of Artificial Intelligence in Drug Safety

AI is transforming pharmacovigilance by improving adverse event management, coding, and signal prioritization. This does not replace medical judgment but enhances productivity and consistency. By implementing human-in-the-loop AI controls, organizations improve scalability and adherence to regulatory standards, ensuring robust safety processes and risk mitigation tactics.

Regional Dynamics in Global Pharmacovigilance

Certain regions, like North America and Europe, lead in pharmacovigilance software adoption due to established regulatory infrastructures and compliance needs. In Asia-Pacific and Latin America, growing regulatory frameworks increase software demand, expanding opportunities for market entry and strategic growth. High adoption rates in the Middle East and Africa indicate rapidly maturing pharmacovigilance capacities.

Strategic Insights for International Groups

Groups like ASEAN, GCC, EU, BRICS, G7, and NATO present distinct opportunities for software deployment. Each region's specific regulatory climates and strategic importance make them crucial for pharmacovigilance solutions that ensure compliant and effective drug safety operations on a global scale.

Country-Specific Insights

The US, UK, Germany, and Japan show strong pharmacovigilance software use, driven by rigorous regulatory standards. These countries' sophisticated markets highlight opportunities for competitive advantage and strategic industry entry. Moreover, emerging markets in countries like Brazil, India, and China offer growth potential as they enhance their pharmacovigilance infrastructures.

Actionable Recommendations for Industry Leaders

Organizations should prioritize platforms that offer compliance, automation, and integration. Emphasis on real-time data governance, robust security, and operational excellence is crucial. Executives are encouraged to redesign operational models alongside technological upgrades to maintain sustainability and compliance.

Impacts of Tariffs and Trade Policies

Current tariffs influence the cost dynamics and competitiveness of pharmacovigilance products globally, necessitating strategies to navigate and mitigate associated risks. This consideration is vital for adaptive market strategies and ensuring continued access across international markets.

Key Takeaways from This Report

- The market for pharmacovigilance software is expanding, strongly influenced by regulatory demands and technological advancements.

- AI technology is enhancing the capability and efficiency of pharmacovigilance processes without replacing essential medical expertise.

- Strategic insights highlight regional and national variations, emphasizing the importance of tailored compliance and operational strategies for market success.Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. Market Size & Growth Trends

3.4. Market Share Analysis, 2025

3.5. FPNV Positioning Matrix, 2025

3.6. New Revenue Opportunities

3.7. Next-Generation Business Models

3.8. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pharmacovigilance & Drug Safety Software Market, by Software Type

7.1. Adverse Event Reporting Software

7.2. Drug Safety Audits Software

7.3. Issue Tracking Software

7.4. Risk Management Software

7.5. Signal Detection Software

7.6. Case Data Analysis Software

7.7. Compliance & Regulatory Reporting Software

8. Pharmacovigilance & Drug Safety Software Market, by Organization Size

8.1. Large Enterprise

8.2. Small And Medium Enterprise

9. Pharmacovigilance & Drug Safety Software Market, by Pharmacovigilance Type

9.1. In-House Pharmacovigilance

9.2. Outsourced Pharmacovigilance

10. Pharmacovigilance & Drug Safety Software Market, by Deployment Mode

10.1. Cloud

10.1.1. Private Cloud

10.1.2. Public Cloud

10.2. On Premise

11. Pharmacovigilance & Drug Safety Software Market, by Clinical Trial Phase

11.1. Preclinical

11.2. Phase I

11.3. Phase II

11.4. Phase III

11.5. Phase IV

12. Pharmacovigilance & Drug Safety Software Market, by End User

12.1. Contract Research Organizations

12.2. Pharmaceutical And Biotech Companies

12.3. Biotechnology Companies

12.4. Medical Device Manufacturers

12.5. Regulatory Authorities

12.6. Hospitals & Healthcare Providers

13. Pharmacovigilance & Drug Safety Software Market, by Application

13.1. Adverse Event Case Management

13.2. Aggregate Reporting

13.3. Risk Communication

13.4. Risk Management

14. Asia-Pacific Pharmacovigilance & Drug Safety Software Market

15. North America Pharmacovigilance & Drug Safety Software Market

16. Latin America Pharmacovigilance & Drug Safety Software Market

17. Europe Pharmacovigilance & Drug Safety Software Market

18. Middle East Pharmacovigilance & Drug Safety Software Market

19. Africa Pharmacovigilance & Drug Safety Software Market

20. ASEAN Pharmacovigilance & Drug Safety Software Market

21. GCC Pharmacovigilance & Drug Safety Software Market

22. European Union Pharmacovigilance & Drug Safety Software Market

23. BRICS Pharmacovigilance & Drug Safety Software Market

24. G7 Pharmacovigilance & Drug Safety Software Market

25. NATO Pharmacovigilance & Drug Safety Software Market

26. United States Pharmacovigilance & Drug Safety Software Market

27. Canada Pharmacovigilance & Drug Safety Software Market

28. Mexico Pharmacovigilance & Drug Safety Software Market

29. Brazil Pharmacovigilance & Drug Safety Software Market

30. United Kingdom Pharmacovigilance & Drug Safety Software Market

31. Germany Pharmacovigilance & Drug Safety Software Market

32. France Pharmacovigilance & Drug Safety Software Market

33. Russia Pharmacovigilance & Drug Safety Software Market

34. Italy Pharmacovigilance & Drug Safety Software Market

35. Spain Pharmacovigilance & Drug Safety Software Market

36. China Pharmacovigilance & Drug Safety Software Market

37. India Pharmacovigilance & Drug Safety Software Market

38. Japan Pharmacovigilance & Drug Safety Software Market

39. Australia Pharmacovigilance & Drug Safety Software Market

40. South Korea Pharmacovigilance & Drug Safety Software Market

41. Competitive Landscape

41.1. Market Concentration Analysis, 2025

41.1.1. Concentration Ratio (CR)

41.1.2. Herfindahl Hirschman Index (HHI)

41.2. Recent Developments & Impact Analysis, 2025

41.3. Product Portfolio Analysis, 2025

41.4. Benchmarking Analysis, 2025

42. Company Profiles

42.1. 4C Pharma Solutions

42.2. AB Cube S.A.S.

42.3. Accenture PLC

42.4. Anju Software, Inc.

42.5. ArisGlobal LLC

42.6. Certara, Inc.

42.7. Clarivate

42.8. Clinevo Technologies Private Limited

42.9. Cloudbyz, Inc.

42.10. Cognizant Technology Solutions Corporation

42.11. Ennov SAS

42.12. Ergomed PLC

42.13. Extedo GmbH

42.14. Freyr Software Services Pvt. Ltd.

42.15. Indegene Inc.

42.16. Infosys Limited

42.17. IQVIA Inc.

42.18. NUVO Consultancy

42.19. Oracle Corporation

42.20. PureSoftware Limited

42.21. Sarjen Systems Private Limited

42.22. Sparta Systems, Inc.

42.23. Tepsivo Oy

42.24. TriNetX, LLC

42.25. United BioSource LLC

42.26. Wipro Limited

For more information about this report visit https://www.researchandmarkets.com/r/wh9vc5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment